Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Research Report 2025(Status and Outlook)
Report Overview
Age-Related Macular Degeneration (AMD) Treatment Drugs are a class of pharmaceutical products specifically designed to address the symptoms and progression of Age-Related Macular Degeneration, a leading cause of vision loss in individuals over the age of 50. These drugs work by targeting the underlying causes of AMD, such as neovascularization (growth of abnormal blood vessels) and geographic atrophy (thinning of the retina). The treatment drugs can include anti-angiogenic agents that inhibit the growth of new blood vessels, anti-inflammatory medications to reduce inflammation in the eye, and other therapies aimed at slowing the progression of the disease. They are typically administered through injections into the eye, and their selection and use are guided by the specific type and stage of AMD a patient has, as well as their overall health and response to treatment. The goal of these drugs is to preserve or improve vision and prevent further deterioration of the macula, the central part of the retina responsible for sharp, central vision.
This report provides a deep insight into the global Age-Related Macular Degeneration (AMD) Treatment Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Age-Related Macular Degeneration (AMD) Treatment Drugs market in any manner.
Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ionis Pharmaceuticals
Inc
Bausch Health Companies Inc
Regeneron Pharmaceuticals Inc
Biogen
Novartis AG
Sanofi S.A.
Bayer AG
Coherus Biosciences Inc
F. Hoffmann-La Roche Ltd
Apellis Pharmaceuticals Inc
AbbVie
Pfizer Inc.
Amgen Inc.
Samsung Bioepis
Market Segmentation (by Type)
Aflibercept
Ranibizumab
Others
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Age-Related Macular Degeneration (AMD) Treatment Drugs Market
Overview of the regional outlook of the Age-Related Macular Degeneration (AMD) Treatment Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-Related Macular Degeneration (AMD) Treatment Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Age-Related Macular Degeneration (AMD) Treatment Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Age-Related Macular Degeneration (AMD) Treatment Drugs are a class of pharmaceutical products specifically designed to address the symptoms and progression of Age-Related Macular Degeneration, a leading cause of vision loss in individuals over the age of 50. These drugs work by targeting the underlying causes of AMD, such as neovascularization (growth of abnormal blood vessels) and geographic atrophy (thinning of the retina). The treatment drugs can include anti-angiogenic agents that inhibit the growth of new blood vessels, anti-inflammatory medications to reduce inflammation in the eye, and other therapies aimed at slowing the progression of the disease. They are typically administered through injections into the eye, and their selection and use are guided by the specific type and stage of AMD a patient has, as well as their overall health and response to treatment. The goal of these drugs is to preserve or improve vision and prevent further deterioration of the macula, the central part of the retina responsible for sharp, central vision.
This report provides a deep insight into the global Age-Related Macular Degeneration (AMD) Treatment Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Age-Related Macular Degeneration (AMD) Treatment Drugs market in any manner.
Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ionis Pharmaceuticals
Inc
Bausch Health Companies Inc
Regeneron Pharmaceuticals Inc
Biogen
Novartis AG
Sanofi S.A.
Bayer AG
Coherus Biosciences Inc
F. Hoffmann-La Roche Ltd
Apellis Pharmaceuticals Inc
AbbVie
Pfizer Inc.
Amgen Inc.
Samsung Bioepis
Market Segmentation (by Type)
Aflibercept
Ranibizumab
Others
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Age-Related Macular Degeneration (AMD) Treatment Drugs Market
Overview of the regional outlook of the Age-Related Macular Degeneration (AMD) Treatment Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-Related Macular Degeneration (AMD) Treatment Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Age-Related Macular Degeneration (AMD) Treatment Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Age-Related Macular Degeneration (AMD) Treatment Drugs
1.2 Key Market Segments
1.2.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Segment by Type
1.2.2 Age-Related Macular Degeneration (AMD) Treatment Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Product Life Cycle
3.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Manufacturers (2020-2025)
3.4 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Competitive Situation and Trends
3.8.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) Treatment Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Age-Related Macular Degeneration (AMD) Treatment Drugs Market
5.7 ESG Ratings of Leading Companies
6 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Type (2020-2025)
6.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Price by Type (2020-2025)
7 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Sales by Application (2020-2025)
7.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Growth Rate by Application (2020-2025)
8 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET SALES BY REGION
8.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region
8.1.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region
8.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region
8.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
8.2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
8.2.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country
8.3.2 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country
8.4.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region
8.5.2 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country
8.6.2 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region
8.7.2 Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Age-Related Macular Degeneration (AMD) Treatment Drugs by Region(2020-2025)
9.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production
9.4.1 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production Growth Rate (2020-2025)
9.4.2 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production
9.5.1 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production (2020-2025)
9.6.1 Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Age-Related Macular Degeneration (AMD) Treatment Drugs Production (2020-2025)
9.7.1 China Age-Related Macular Degeneration (AMD) Treatment Drugs Production Growth Rate (2020-2025)
9.7.2 China Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ionis Pharmaceuticals
10.1.1 Ionis Pharmaceuticals Basic Information
10.1.2 Ionis Pharmaceuticals Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.1.3 Ionis Pharmaceuticals Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.1.4 Ionis Pharmaceuticals Business Overview
10.1.5 Ionis Pharmaceuticals SWOT Analysis
10.1.6 Ionis Pharmaceuticals Recent Developments
10.2 Inc
10.2.1 Inc Basic Information
10.2.2 Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.2.3 Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.2.4 Inc Business Overview
10.2.5 Inc SWOT Analysis
10.2.6 Inc Recent Developments
10.3 Bausch Health Companies Inc
10.3.1 Bausch Health Companies Inc Basic Information
10.3.2 Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.3.3 Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.3.4 Bausch Health Companies Inc Business Overview
10.3.5 Bausch Health Companies Inc SWOT Analysis
10.3.6 Bausch Health Companies Inc Recent Developments
10.4 Regeneron Pharmaceuticals Inc
10.4.1 Regeneron Pharmaceuticals Inc Basic Information
10.4.2 Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.4.3 Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.4.4 Regeneron Pharmaceuticals Inc Business Overview
10.4.5 Regeneron Pharmaceuticals Inc Recent Developments
10.5 Biogen
10.5.1 Biogen Basic Information
10.5.2 Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.5.3 Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.5.4 Biogen Business Overview
10.5.5 Biogen Recent Developments
10.6 Novartis AG
10.6.1 Novartis AG Basic Information
10.6.2 Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.6.3 Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.6.4 Novartis AG Business Overview
10.6.5 Novartis AG Recent Developments
10.7 Sanofi S.A.
10.7.1 Sanofi S.A. Basic Information
10.7.2 Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.7.3 Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.7.4 Sanofi S.A. Business Overview
10.7.5 Sanofi S.A. Recent Developments
10.8 Bayer AG
10.8.1 Bayer AG Basic Information
10.8.2 Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.8.3 Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.8.4 Bayer AG Business Overview
10.8.5 Bayer AG Recent Developments
10.9 Coherus Biosciences Inc
10.9.1 Coherus Biosciences Inc Basic Information
10.9.2 Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.9.3 Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.9.4 Coherus Biosciences Inc Business Overview
10.9.5 Coherus Biosciences Inc Recent Developments
10.10 F. Hoffmann-La Roche Ltd
10.10.1 F. Hoffmann-La Roche Ltd Basic Information
10.10.2 F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.10.3 F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.10.4 F. Hoffmann-La Roche Ltd Business Overview
10.10.5 F. Hoffmann-La Roche Ltd Recent Developments
10.11 Apellis Pharmaceuticals Inc
10.11.1 Apellis Pharmaceuticals Inc Basic Information
10.11.2 Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.11.3 Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.11.4 Apellis Pharmaceuticals Inc Business Overview
10.11.5 Apellis Pharmaceuticals Inc Recent Developments
10.12 AbbVie
10.12.1 AbbVie Basic Information
10.12.2 AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.12.3 AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.12.4 AbbVie Business Overview
10.12.5 AbbVie Recent Developments
10.13 Pfizer Inc.
10.13.1 Pfizer Inc. Basic Information
10.13.2 Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.13.3 Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.13.4 Pfizer Inc. Business Overview
10.13.5 Pfizer Inc. Recent Developments
10.14 Amgen Inc.
10.14.1 Amgen Inc. Basic Information
10.14.2 Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.14.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.14.4 Amgen Inc. Business Overview
10.14.5 Amgen Inc. Recent Developments
10.15 Samsung Bioepis
10.15.1 Samsung Bioepis Basic Information
10.15.2 Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.15.3 Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.15.4 Samsung Bioepis Business Overview
10.15.5 Samsung Bioepis Recent Developments
11 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET FORECAST BY REGION
11.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast
11.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Region
11.2.4 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Age-Related Macular Degeneration (AMD) Treatment Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type (2026-2033)
12.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type (2026-2033)
12.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Forecast by Application (2026-2033)
12.2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) Forecast by Application
12.2.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Age-Related Macular Degeneration (AMD) Treatment Drugs
1.2 Key Market Segments
1.2.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Segment by Type
1.2.2 Age-Related Macular Degeneration (AMD) Treatment Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Product Life Cycle
3.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Manufacturers (2020-2025)
3.4 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Competitive Situation and Trends
3.8.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) Treatment Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Age-Related Macular Degeneration (AMD) Treatment Drugs Market
5.7 ESG Ratings of Leading Companies
6 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Type (2020-2025)
6.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Price by Type (2020-2025)
7 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Sales by Application (2020-2025)
7.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Growth Rate by Application (2020-2025)
8 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET SALES BY REGION
8.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region
8.1.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region
8.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region
8.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
8.2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
8.2.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country
8.3.2 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country
8.4.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region
8.5.2 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country
8.6.2 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region
8.7.2 Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Age-Related Macular Degeneration (AMD) Treatment Drugs by Region(2020-2025)
9.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production
9.4.1 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production Growth Rate (2020-2025)
9.4.2 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production
9.5.1 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production (2020-2025)
9.6.1 Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Age-Related Macular Degeneration (AMD) Treatment Drugs Production (2020-2025)
9.7.1 China Age-Related Macular Degeneration (AMD) Treatment Drugs Production Growth Rate (2020-2025)
9.7.2 China Age-Related Macular Degeneration (AMD) Treatment Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ionis Pharmaceuticals
10.1.1 Ionis Pharmaceuticals Basic Information
10.1.2 Ionis Pharmaceuticals Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.1.3 Ionis Pharmaceuticals Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.1.4 Ionis Pharmaceuticals Business Overview
10.1.5 Ionis Pharmaceuticals SWOT Analysis
10.1.6 Ionis Pharmaceuticals Recent Developments
10.2 Inc
10.2.1 Inc Basic Information
10.2.2 Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.2.3 Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.2.4 Inc Business Overview
10.2.5 Inc SWOT Analysis
10.2.6 Inc Recent Developments
10.3 Bausch Health Companies Inc
10.3.1 Bausch Health Companies Inc Basic Information
10.3.2 Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.3.3 Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.3.4 Bausch Health Companies Inc Business Overview
10.3.5 Bausch Health Companies Inc SWOT Analysis
10.3.6 Bausch Health Companies Inc Recent Developments
10.4 Regeneron Pharmaceuticals Inc
10.4.1 Regeneron Pharmaceuticals Inc Basic Information
10.4.2 Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.4.3 Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.4.4 Regeneron Pharmaceuticals Inc Business Overview
10.4.5 Regeneron Pharmaceuticals Inc Recent Developments
10.5 Biogen
10.5.1 Biogen Basic Information
10.5.2 Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.5.3 Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.5.4 Biogen Business Overview
10.5.5 Biogen Recent Developments
10.6 Novartis AG
10.6.1 Novartis AG Basic Information
10.6.2 Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.6.3 Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.6.4 Novartis AG Business Overview
10.6.5 Novartis AG Recent Developments
10.7 Sanofi S.A.
10.7.1 Sanofi S.A. Basic Information
10.7.2 Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.7.3 Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.7.4 Sanofi S.A. Business Overview
10.7.5 Sanofi S.A. Recent Developments
10.8 Bayer AG
10.8.1 Bayer AG Basic Information
10.8.2 Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.8.3 Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.8.4 Bayer AG Business Overview
10.8.5 Bayer AG Recent Developments
10.9 Coherus Biosciences Inc
10.9.1 Coherus Biosciences Inc Basic Information
10.9.2 Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.9.3 Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.9.4 Coherus Biosciences Inc Business Overview
10.9.5 Coherus Biosciences Inc Recent Developments
10.10 F. Hoffmann-La Roche Ltd
10.10.1 F. Hoffmann-La Roche Ltd Basic Information
10.10.2 F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.10.3 F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.10.4 F. Hoffmann-La Roche Ltd Business Overview
10.10.5 F. Hoffmann-La Roche Ltd Recent Developments
10.11 Apellis Pharmaceuticals Inc
10.11.1 Apellis Pharmaceuticals Inc Basic Information
10.11.2 Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.11.3 Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.11.4 Apellis Pharmaceuticals Inc Business Overview
10.11.5 Apellis Pharmaceuticals Inc Recent Developments
10.12 AbbVie
10.12.1 AbbVie Basic Information
10.12.2 AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.12.3 AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.12.4 AbbVie Business Overview
10.12.5 AbbVie Recent Developments
10.13 Pfizer Inc.
10.13.1 Pfizer Inc. Basic Information
10.13.2 Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.13.3 Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.13.4 Pfizer Inc. Business Overview
10.13.5 Pfizer Inc. Recent Developments
10.14 Amgen Inc.
10.14.1 Amgen Inc. Basic Information
10.14.2 Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.14.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.14.4 Amgen Inc. Business Overview
10.14.5 Amgen Inc. Recent Developments
10.15 Samsung Bioepis
10.15.1 Samsung Bioepis Basic Information
10.15.2 Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
10.15.3 Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Product Market Performance
10.15.4 Samsung Bioepis Business Overview
10.15.5 Samsung Bioepis Recent Developments
11 AGE-RELATED MACULAR DEGENERATION (AMD) TREATMENT DRUGS MARKET FORECAST BY REGION
11.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast
11.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Region
11.2.4 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Age-Related Macular Degeneration (AMD) Treatment Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type (2026-2033)
12.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type (2026-2033)
12.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Forecast by Application (2026-2033)
12.2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) Forecast by Application
12.2.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Comparison by Region (M USD)
Table 5. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) Treatment Drugs as of 2024)
Table 10. Global Market Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Type (K Units)
Table 26. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Type (M USD)
Table 27. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) by Type (2020-2025)
Table 28. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Type (2020-2025)
Table 29. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) by Type (2020-2025)
Table 30. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Share by Type (2020-2025)
Table 31. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Price (USD/Unit) by Type (2020-2025)
Table 32. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) by Application
Table 33. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Application
Table 34. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Application (2020-2025) & (K Units)
Table 35. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Application (2020-2025)
Table 36. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Application (2020-2025) & (M USD)
Table 37. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Application (2020-2025)
Table 38. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Growth Rate by Application (2020-2025)
Table 39. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 40. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region (2020-2025)
Table 41. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region (2020-2025) & (M USD)
Table 42. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region (2020-2025)
Table 43. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 44. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region (2020-2025) & (M USD)
Table 49. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 50. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region (2020-2025) & (M USD)
Table 53. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) by Region(2020-2025)
Table 54. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Region (2020-2025)
Table 56. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Ionis Pharmaceuticals Basic Information
Table 62. Ionis Pharmaceuticals Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 63. Ionis Pharmaceuticals Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Ionis Pharmaceuticals Business Overview
Table 65. Ionis Pharmaceuticals SWOT Analysis
Table 66. Ionis Pharmaceuticals Recent Developments
Table 67. Inc Basic Information
Table 68. Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 69. Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Inc Business Overview
Table 71. Inc SWOT Analysis
Table 72. Inc Recent Developments
Table 73. Bausch Health Companies Inc Basic Information
Table 74. Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 75. Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bausch Health Companies Inc Business Overview
Table 77. Bausch Health Companies Inc SWOT Analysis
Table 78. Bausch Health Companies Inc Recent Developments
Table 79. Regeneron Pharmaceuticals Inc Basic Information
Table 80. Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 81. Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Regeneron Pharmaceuticals Inc Business Overview
Table 83. Regeneron Pharmaceuticals Inc Recent Developments
Table 84. Biogen Basic Information
Table 85. Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 86. Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Biogen Business Overview
Table 88. Biogen Recent Developments
Table 89. Novartis AG Basic Information
Table 90. Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 91. Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Recent Developments
Table 94. Sanofi S.A. Basic Information
Table 95. Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 96. Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Sanofi S.A. Business Overview
Table 98. Sanofi S.A. Recent Developments
Table 99. Bayer AG Basic Information
Table 100. Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 101. Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Bayer AG Business Overview
Table 103. Bayer AG Recent Developments
Table 104. Coherus Biosciences Inc Basic Information
Table 105. Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 106. Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Coherus Biosciences Inc Business Overview
Table 108. Coherus Biosciences Inc Recent Developments
Table 109. F. Hoffmann-La Roche Ltd Basic Information
Table 110. F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 111. F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. F. Hoffmann-La Roche Ltd Business Overview
Table 113. F. Hoffmann-La Roche Ltd Recent Developments
Table 114. Apellis Pharmaceuticals Inc Basic Information
Table 115. Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 116. Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Apellis Pharmaceuticals Inc Business Overview
Table 118. Apellis Pharmaceuticals Inc Recent Developments
Table 119. AbbVie Basic Information
Table 120. AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 121. AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. AbbVie Business Overview
Table 123. AbbVie Recent Developments
Table 124. Pfizer Inc. Basic Information
Table 125. Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 126. Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Pfizer Inc. Business Overview
Table 128. Pfizer Inc. Recent Developments
Table 129. Amgen Inc. Basic Information
Table 130. Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 131. Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Amgen Inc. Business Overview
Table 133. Amgen Inc. Recent Developments
Table 134. Samsung Bioepis Basic Information
Table 135. Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 136. Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Samsung Bioepis Business Overview
Table 138. Samsung Bioepis Recent Developments
Table 139. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Comparison by Region (M USD)
Table 5. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) Treatment Drugs as of 2024)
Table 10. Global Market Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Type (K Units)
Table 26. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Type (M USD)
Table 27. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) by Type (2020-2025)
Table 28. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Type (2020-2025)
Table 29. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) by Type (2020-2025)
Table 30. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Share by Type (2020-2025)
Table 31. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Price (USD/Unit) by Type (2020-2025)
Table 32. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) by Application
Table 33. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Application
Table 34. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Application (2020-2025) & (K Units)
Table 35. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Application (2020-2025)
Table 36. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Application (2020-2025) & (M USD)
Table 37. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Application (2020-2025)
Table 38. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Growth Rate by Application (2020-2025)
Table 39. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 40. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region (2020-2025)
Table 41. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region (2020-2025) & (M USD)
Table 42. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region (2020-2025)
Table 43. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 44. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region (2020-2025) & (M USD)
Table 49. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2020-2025) & (K Units)
Table 50. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region (2020-2025) & (M USD)
Table 53. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) by Region(2020-2025)
Table 54. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Region (2020-2025)
Table 56. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Ionis Pharmaceuticals Basic Information
Table 62. Ionis Pharmaceuticals Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 63. Ionis Pharmaceuticals Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Ionis Pharmaceuticals Business Overview
Table 65. Ionis Pharmaceuticals SWOT Analysis
Table 66. Ionis Pharmaceuticals Recent Developments
Table 67. Inc Basic Information
Table 68. Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 69. Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Inc Business Overview
Table 71. Inc SWOT Analysis
Table 72. Inc Recent Developments
Table 73. Bausch Health Companies Inc Basic Information
Table 74. Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 75. Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bausch Health Companies Inc Business Overview
Table 77. Bausch Health Companies Inc SWOT Analysis
Table 78. Bausch Health Companies Inc Recent Developments
Table 79. Regeneron Pharmaceuticals Inc Basic Information
Table 80. Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 81. Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Regeneron Pharmaceuticals Inc Business Overview
Table 83. Regeneron Pharmaceuticals Inc Recent Developments
Table 84. Biogen Basic Information
Table 85. Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 86. Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Biogen Business Overview
Table 88. Biogen Recent Developments
Table 89. Novartis AG Basic Information
Table 90. Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 91. Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Recent Developments
Table 94. Sanofi S.A. Basic Information
Table 95. Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 96. Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Sanofi S.A. Business Overview
Table 98. Sanofi S.A. Recent Developments
Table 99. Bayer AG Basic Information
Table 100. Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 101. Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Bayer AG Business Overview
Table 103. Bayer AG Recent Developments
Table 104. Coherus Biosciences Inc Basic Information
Table 105. Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 106. Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Coherus Biosciences Inc Business Overview
Table 108. Coherus Biosciences Inc Recent Developments
Table 109. F. Hoffmann-La Roche Ltd Basic Information
Table 110. F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 111. F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. F. Hoffmann-La Roche Ltd Business Overview
Table 113. F. Hoffmann-La Roche Ltd Recent Developments
Table 114. Apellis Pharmaceuticals Inc Basic Information
Table 115. Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 116. Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Apellis Pharmaceuticals Inc Business Overview
Table 118. Apellis Pharmaceuticals Inc Recent Developments
Table 119. AbbVie Basic Information
Table 120. AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 121. AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. AbbVie Business Overview
Table 123. AbbVie Recent Developments
Table 124. Pfizer Inc. Basic Information
Table 125. Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 126. Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Pfizer Inc. Business Overview
Table 128. Pfizer Inc. Recent Developments
Table 129. Amgen Inc. Basic Information
Table 130. Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 131. Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Amgen Inc. Business Overview
Table 133. Amgen Inc. Recent Developments
Table 134. Samsung Bioepis Basic Information
Table 135. Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Product Overview
Table 136. Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Samsung Bioepis Business Overview
Table 138. Samsung Bioepis Recent Developments
Table 139. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Age-Related Macular Degeneration (AMD) Treatment Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD), 2024-2033
Figure 5. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Product Life Cycle
Figure 13. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Share by Manufacturers in 2024
Figure 15. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue in 2024
Figure 18. Industry Chain Map of Age-Related Macular Degeneration (AMD) Treatment Drugs
Figure 19. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market PEST Analysis
Figure 20. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Type
Figure 27. Sales Market Share of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type in 2024
Figure 29. Market Size Share of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type (2020-2025)
Figure 30. Market Size Share of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Application
Figure 33. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Application in 2024
Figure 35. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Application (2020-2025)
Figure 36. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Application in 2024
Figure 37. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region (2020-2025)
Figure 40. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Country in 2024
Figure 43. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Country in 2024
Figure 45. U.S. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Country in 2024
Figure 53. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Country in 2024
Figure 55. Germany Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region in 2024
Figure 68. China Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (K Units)
Figure 79. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Country in 2024
Figure 80. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Country in 2024
Figure 82. Brazil Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share Forecast by Type (2026-2033)
Figure 111. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Application (2026-2033)
Figure 112. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Age-Related Macular Degeneration (AMD) Treatment Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD), 2024-2033
Figure 5. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Product Life Cycle
Figure 13. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Share by Manufacturers in 2024
Figure 15. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue in 2024
Figure 18. Industry Chain Map of Age-Related Macular Degeneration (AMD) Treatment Drugs
Figure 19. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market PEST Analysis
Figure 20. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Type
Figure 27. Sales Market Share of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type in 2024
Figure 29. Market Size Share of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type (2020-2025)
Figure 30. Market Size Share of Age-Related Macular Degeneration (AMD) Treatment Drugs by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Application
Figure 33. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Application in 2024
Figure 35. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Application (2020-2025)
Figure 36. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Application in 2024
Figure 37. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region (2020-2025)
Figure 40. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Country in 2024
Figure 43. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Country in 2024
Figure 45. U.S. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Age-Related Macular Degeneration (AMD) Treatment Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Country in 2024
Figure 53. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Country in 2024
Figure 55. Germany Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region in 2024
Figure 68. China Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (K Units)
Figure 79. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Country in 2024
Figure 80. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Country in 2024
Figure 82. Brazil Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China Age-Related Macular Degeneration (AMD) Treatment Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share Forecast by Type (2026-2033)
Figure 111. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Forecast by Application (2026-2033)
Figure 112. Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share Forecast by Application (2026-2033)
